Samsung Biologics Co., Ltd. is engaged in manufacturing biopharmaceutical products through cell culture, purification, analytical testing, fill & finish, and packaging. The company's biotech drugs includes treatment for cancer, diabetes, rheumatoid arthritis, among others. Samsung Biologics Co., Ltd. also offers clinical and commercial bulk cGMP manufacturing of drug substances and drug products, cell line generation, process and analytical method development, and analytical services. The company is based in Incheon, South Korea. Samsung Biologics Co., Ltd. was established in 2011 as a joint venture between Samsung Electronics Co., Samsung Everland Inc., Samsung C&T Corp., and Quintiles Transnational Corp.
Headquarters
300 Songdo Bio Way (Daero), Yeonsu-Gu
Incheon; Incheon;
Contact Details: Purchase the Samsung Biologics Co., Ltd. report to view the information.
Website: http://www.samsungbiologics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service